Section Arrow
CRIS.NASDAQ
- Curis
(Financial Status)
Quotes are at least 15-min delayed:2026/01/07 18:32 EST
After Hours
Last
 0.8599
+0.0196 (+2.33%)
Bid
0.83
Ask
0.8598
High 0.8699 
Low 0.82 
Volume 151.05K 
Regular Hours (Closed)
Last
 0.8403
-0.1597 (-15.97%)
Day High 
0.9379 
Prev. Close
1-M High
1.409 
Volume 
15.30M 
Bid
0.83
Ask
0.8598
Day Low
0.771 
Open
0.91285 
1-M Low
0.96 
Market Cap 
12.93M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 1.02 
20-SMA 1.12 
50-SMA 1.24 
52-W High 3.65 
52-W Low 0.96 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-3.30/-2.54
Enterprise Value
14.55M
Balance Sheet
Book Value Per Share
-1.14
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
7.88M
Operating Revenue Per Share
0.79
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
ASBPAspire Biopharma Holdings Inc.0.1256+0.0206+19.62%-- 
After Hours 0.1276 +0.002 +1.59%
ERASErasca5.17+1.54+42.42%-- 
After Hours 4.55 -0.62 -11.99%
RXRXRecursion Pharmaceuticals4.86+0.31+6.81%-- 
After Hours 4.78 -0.08 -1.65%
VTYXVentyx Biosciences13.73+3.68+36.62%-- 
After Hours 13.73 0 0.00%
GLUEMonte Rosa Therapeutics23.28+7.27+45.41%54.09PE
After Hours 23.22 -0.06 -0.26%
Industry overview quotes are at least 15 minutes delayed
Business Description
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.